⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
EcoVadis and Watershed partner to close the Scope 3 data gap
prnewswire.com
JNJ
JPM
FDX
V
Mestag Therapeutics to Present Data on Targeted LTBR Agonist MST-0312 at Cancer Immunotherapy Keystone Symposia
globenewswire.com
MRK
JNJ
GOOG
Mestag Therapeutics to Present Data on Targeted LTBR Agonist MST-0312 at Cancer Immunotherapy Keystone Symposia
globenewswire.com
MRK
JNJ
GOOG
Demande d’autorisation de mise sur le marché de TECVAYLI®▼ (teclistamab) en monothérapie soumise à l’EMA pour le myélome multiple en rechute ou réfractaire après au moins une ligne de traitement antérieure
globenewswire.com
JNJ
Antrag bei der EMA für die TECVAYLI®▼ (teclistamab)-Monotherapie zur Behandlung des rezidivierten/refraktären multiplen Myeloms nach mindestens einer vorherigen Therapie eingereicht
globenewswire.com
JNJ
BioGene Therapeutics Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director Ready to Announce with Confidence?
newsfilecorp.com
RLMD
JNJ
Global Minimally Invasive Surgical Devices Market to Witness Upsurge in Growth at a CAGR of ~7% by 2034 | DelveInsight
prnewswire.com
ABT
ISRG
SYK
JNJ
MDT
BSX
CNMD
COO
ANGI
FF
ZBH
MPW
APYX
ASNS
GMED
SN
UTMD
TLF
Executive Panel to Discuss Yard Operations as an Emerging Supply Chain Risk
prnewswire.com
JNJ
MAT
KHC
GO
La Commission européenne approuve AKEEGA® (comprimé à double action de niraparib et d’acétate d’abiratérone) pour le traitement des patients atteints d’un cancer de la prostate hormonosensible métastatique (CPHSm) présentant des mutations BRCA1/2
globenewswire.com
JNJ
GSK
Global Surgical Robotic Systems Market is Set to Reach USD 30 Billion by 2034 Due to the Rising Demand for Precision Surgery | DelveInsight
prnewswire.com
ISRG
STX
JNJ
MDT
GMED
ZBH
ABT
BSX
ANRO
BIIB
GEHC
GOOG
MSFT
IBM
AMZN
AAPL
TSLA